Jonathan Rosand

Prof. Jonathan Rosand


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2018 in Science
Verified
Journal Article
Open access
PDF file
TCThe Brainstorm Consortium
The Brainstorm Consortium
VAVerneri Anttila
Verneri Anttila
BBBrendan Bulik-Sullivan
Brendan Bulik-Sullivan
HFHilary K. Finucane
Hilary K. Finucane
RWRaymond K. Walters
Raymond K. Walters
BNBenjamin M. Neale
Benjamin M. Neale
Brainstorming diseases: Consistent classification of neuropsychiatric diseases is problematic because it can lead to misunderstanding of etiology. The Brainstorm Consortium examined multiple genome-wide association studies drawn from more than 200,000 patients for 25 brain-associated disorders and 17 phenotypes. Broadly, it appears that psychiatric and neurologic disorders share relatively little common genetic risk. However, different and independent pathways can result in similar clinical manifestations (e.g., psychosis, which occurs in both schizophrenia and Alzheimer's disease). Schizophrenia correlated with many psychiatric disorders, whereas the immunopathological affliction Crohn's disease did not, and posttraumatic stress syndrome was also largely independent of underlying traits. Essentially, the earlier the onset of a disorder, the more inheritable it appeared to be. Science , this issue p. eaap8757

1 April 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
DWDaniel Woo
Daniel Woo
GFGuido J. Falcone
Guido J. Falcone
WDWilliam J. Devan
William J. Devan
WBW. Mark Brown
W. Mark Brown
ABAlessandro Biffi
Alessandro Biffi
JRJonathan Rosand
Jonathan Rosand

8 November 2010 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
ABAlessandro Biffi
Alessandro Biffi
ASAkshata Sonni
Akshata Sonni
CAChristopher D. Anderson
Christopher D. Anderson
BKBrett Kissela
Brett Kissela
JJJeremiasz M. Jagiella
Jeremiasz M. Jagiella
OCon behalf of the International Stroke Genetics Consortium
on behalf of the International Stroke Genetics Consortium

1 September 2015 in JAMA
Verified
Journal Article
Open access
PDF file
ABAlessandro Biffi
Alessandro Biffi
CAChristopher D. Anderson
Christopher D. Anderson
TBThomas W. K. Battey
Thomas W. K. Battey
AAAlison M. Ayres
Alison M. Ayres
SGSteven M. Greenberg
Steven M. Greenberg
JRJonathan Rosand
Jonathan Rosand
Intracerebral hemorrhage (ICH) represents the acute manifestation of progressive cerebral small-vessel disease. The 2 predominant pathological forms of cerebral small-vessel disease, arteriolosclerosis and cerebral amyloid angiopathy (CAA), can generally be identified on the basis of ICH location. Arteriolosclerosis-associated ICH occurs most commonly in the deep structures, whereas CAA-associated ICH occurs almost exclusively in the cortical-subcortical regions labeled lobar.1 Quiz Ref ID ICH is the most severe and least treatable form of stroke, responsible for almost 50% of stroke-related morbidity and mortality.2 ICH survivors are at high risk for recurrent ICH,3 and recurrent ICH is generally more severe than the preceding ICH. Improving secondary prevention of ICH is therefore vital.

1 September 2005 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
JRJonathan Rosand
Jonathan Rosand
AMAlona Muzikansky
Alona Muzikansky
AKAshok Kumar
Ashok Kumar
JWJonathan J. Wisco
Jonathan J. Wisco
ESEric E. Smith
Eric E. Smith
SGSteven M. Greenberg
Steven M. Greenberg

1 June 2010 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
ABAlessandro Biffi
Alessandro Biffi
CAChristopher D. Anderson
Christopher D. Anderson
RDRahul S. Desikan
Rahul S. Desikan
MSMert Sabuncu
Mert Sabuncu
LCLynelle Cortellini
Lynelle Cortellini
JRJonathan Rosand
Jonathan Rosand
Late-onset Alzheimer disease (AD) is the most common cause of dementia and the fifth leading cause of death in Americans older than 65 years.1 The mechanisms underlying AD onset and progression remain largely unexplained. A study of twins2 has demonstrated a significant role for genetics in late-onset AD, with heritability estimates of 60% to 80%. Until recently, the only genetic variant consistently shown to influence AD risk and age at onset was APOE (OMIM 107741).3 New findings from genome-wide association studies (GWASs) identified 3 additional loci conferring risk for AD: CLU (OMIM 185430), PICALM (OMIM 603025), and CR1 (OMIM 120620).4,5 Other promising loci were also reported in these GWASs but did not achieve P values sufficient for genome-wide significance.